2011 - Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP

Frieden, Rick
June 2011
ACP Journal Club;6/21/2011, Vol. 154 Issue 6, p4
Academic Journal
The article focuses on a study by Sandset E. C. and colleagues which shows that candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated blood pressure (BP). The results of the study show that mean BP was lower with candesartan than placebo at 7 days but not at 6 months. The study showed that the outcomes in patients receiving candesartan were slightly worse than in those receiving placebo.


Related Articles

  • 2011 - Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP. Frieden, Rick // ACP Journal Club;6/21/2011, Vol. 154 Issue 6, p4 

    Question Does candesartan improve clinical or functional outcomes in patients with acute stroke and elevated blood pressure (BP)? Methods Design Randomized placebo-controlled trial (Scandinavian Candesartan Acute Stroke Trial [SCAST]). ClinicalTrials.gov NCT00120003, Current Controlled Trials...

  • Management of Hypertension in the Acute Phase of Stroke. Bornes, Troy D.; Butcher, Ken S. // Current Hypertension Reviews;2009, Vol. 5 Issue 1, p24 

    An increase in arterial blood pressure (BP) is common following the onset of stroke. Although there is evidence suggesting that this acute elevation of BP is associated with a poor clinical outcome in both ischemic and hemorrhagic stroke patients, optimal treatment strategies are currently...

  • Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension. Plosker, Greg L.; Keam, Susan J. // PharmacoEconomics;2006, Vol. 24 Issue 12, p1249 

    The addition of candesartan cilexetil (Atacand, Amias, Blopress, Kenzen, Ratacand) to standard therapy for chronic heart failure (CHF) provided important clinical benefits at little or no additional cost in France, Germany and the UK, according to a detailed economic analysis focusing on major...

  • Management of acute stroke in the elderly: follow-up of a controlled trial. Garraway, W.M.; Akhtar, A.J.; Hockey, L.; Prescott, R.J. // British Medical Journal;9/27/1980, Vol. 281 Issue 6244, p827 

    Assesses the management of acute stroke in the elderly patients. Factors contributing to the functional outcome; Improvement in the functional outcome in the patients; Continuance of stroke rehabilitation after the acute phase.

  • Candesartan not beneficial in patients with acute stroke and raised BP.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p83 

    The article reports on a study to evaluate the benefit of angiotensin-receptor blocker candesartan in patients with acute stroke and raised blood pressure (BP). It references "The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled,...

  • Candesartan Cilexetil. Hoy, Sheridan M.; Keating, Gillian M. // American Journal of Cardiovascular Drugs;2010, Vol. 10 Issue 5, p335 

    Candesartan cilexetil is the orally administered prodrug of candesartan, an angiotensin II subtype 1 receptor antagonist. The pharmacokinetics (area under the plasma concentration-time curve and maximum plasma concentration) of candesartan do not appear to be affected by age, sex, or weight,...

  • Blood Pressure and Acute Ischemic Stroke. Hill, Michael D. // Canadian Journal of Neurological Sciences;Mar2011, Vol. 38 Issue 2, p187 

    The author reflects on the treatment of acute hypertension in patients with acute ischemic stroke, in which limited guidance is available to justify treatment. He cites the study of J. Zhang and colleagues which shows that acute blood pressure (BP) is associated with the clinical outcome. He...

  • Association between Statin Use and Short-Term Outcome Based on Severity of Ischemic Stroke: A Cohort Study. Song, Bo; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, Chunxue; Wang, Anxin; Du, Wanliang; Wang, Yongjun // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Statins reportedly improve clinical outcomes for ischemic stroke patients. However, it is unclear whether the contribution of statin treatment varies depending on the severity of stroke. We sought to investigate the relationship between statin use and the outcome of acute first-ever...

  • Induced hypertension for the treatment of acute MCA occlusion beyond the thrombolysis window: case report. Bogoslovsky, Tanya; Häppölä, Olli; Salonen, Oili; Lindsberg, Perttu J. // BMC Neurology;2006, Vol. 6, p46 

    Background: A minority of stroke patients is eligible for thrombolytic therapy. Small pilot case series have hinted that elevation of incident arterial blood pressure might be associated with a favorable prognosis either in acute or subacute stroke. However, these patients were not considered...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics